Tamir Tal, CEO, Cordio Medical, explains how AI voice biomarker technology and the advancement of a diagnostic app from a smartphone can transform diagnosis of early diseases.
Read more here.
Tamir Tal, CEO, Cordio Medical, explains how AI voice biomarker technology and the advancement of a diagnostic app from a smartphone can transform diagnosis of early diseases.
![[SeeTrue in PR Newswire] SeeTrue and IDSS bringing the power of AI and CT Open Architecture to Automate Security Screening, with Prohibited Items Detection](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
